Grey Wolf Therapeutics raised $50m in Series B extension led by ICG, joined by Pfizer Ventures, Andera Partners, Canaan, Earlybird, and British Patient. Health services Manufacturing Pharma Investments 15 May 2024 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 50M Round investors: Earlybird Venture CapitalIntermediate Capital GroupOxford Science EnterprisesPfizer Venture InvestmentsAndera PartnersBritish Patient CapitalCanaan Partners Company: Grey Wolf Therapeutics Industry: Health servicesManufacturingPharma
Immutrin in a £65M series A led by Frazier Life Sciences, joined by SR One, Qiming Venture Partners, Cambridge Enterprise Ventures and F-Prime Biotech Health services Manufacturing Pharma Investments 07 March 2026
R1 Therapeutics secured a $77.5 million Series A led by Abingworth, F-Prime Capital and DaVita Venture Group. Biotech Health services Pharma Investments 01 March 2026
Beacon Tx raised $75m in Series C led by Goldman Sachs Alternatives, joined by the RD Fund, Syncona, Forbion, Oxford Science Enterprises, and Advent. Health services Manufacturing Pharma Investments 29 December 2025